Tag: Covidien
Medtronic, Covidien deal approved
January 7, 2015HME News Staff
MINNEAPOLIS - Medtronic shareholders on Tuesday approved a $43 billion dollar acquisition of Covidien.The deal still requires approval from the High Court of Ireland, according to local newspapers.The deal was first announced in June 2014. The combined company, Medtronic PLC, will retain offices in Minneapolis but have its headquarters in Ireland, where Covidien is based. That has drawn criticism for being a “tax dodge,” according to reports.The combined company will have a comprehensive...
In brief: Lawmakers introduce bid bill, SBA hosts stakeholders at hearing
June 20, 2014HME News Staff
WASHINGTON - Reps. Pat Tiberi, R-Ohio, and John Larson, D-Conn., have introduced a bill that would require providers to obtain bid bonds as part of future rounds of competitive bidding. H.R. 4920, the Medicare DMEPOS Competitive Bidding Improvement Act of 2014, would also require providers to prove they meet licensure requirements before they submit bids. “AAHomecare is putting the full weight of the industry behind this practical piece of legislation,” stated Tom Ryan, president and...
Medtronic buys Covidien
June 17, 2014HME News Staff
MINNEAPOLIS and DUBLIN - Medtronic has agreed to buy Covidien in a cash-and-stock transaction valued at about $42.9 billion, the companies announced June 15.
The combined company will have a comprehensive product portfolio, a diversified growth profile and broad geographic reach, with 87,000 employees in more than 150 countries, according to a press release.
“We are excited to reach this agreement with Covidien, which further advances our mission to alleviate pain, restore health and...
Covidien offloads pharmaceuticals division
May 29, 2013HME News Staff
DUBLIN, Ireland - The board of directors at Covidien, a global provider of healthcare products, recently approved the spinoff of its pharmaceuticals business, Hazelwood, Mo.-based Mallinckrodt, according to a press release. Covidien will transfer the pharmaceuticals business to Mallinckrodt, which will operate as an independent, publicly traded company. For every eight ordinary shares of Covidien held, shareholders will receive one ordinary share of Mallinckrodt, the release noted. The move is expected...
Briefs: Pride announces stops for new tour
March 24, 2011HME News Staff
EXETER, Pa. - Pride Mobility and Quantum Rehab announced in February the stops for its new educational tour. The 2011 Professional Education Partnership will stop in 24 cities beginning in Orlando in March and ending in Wilkes-Barre, Pa., in October. The tour features courses like "Mobility Product Troubleshooting and Repair." Speakers include Bill Pierce, a PT who specializes in neuro-rehab at Sacred Heart Medical Center in Eugene, Ore. For a complete schedule and course list, go to www.prideprovider.com.
Invacare...